Synaptosomal-associated protein 25 and Presynaptic cholinergic receptors (SNAP-25 / Presynaptic AChR)

The target complex consisting of Synaptosomal-associated protein 25 (SNAP-25) and presynaptic cholinergic receptors represents the primary regulatory machinery for acetylcholine release at the neuromuscular junction (NMJ). SNAP-25 is a critical t-SNARE protein that facilitates the fusion of synaptic vesicles with the presynaptic membrane, a process essential for muscle contraction (UniProt P60880). Presynaptic cholinergic receptors, including muscarinic (M1, M2) and nicotinic subtypes, serve as autoreceptors that fine-tune the amount of acetylcholine released into the synaptic cleft (Santafe et al., 2006, J. Neurosci. Res.). This system is the therapeutic target for Botulinum neurotoxins, which cleave SNAP-25 to induce localized muscle paralysis (StatPearls, Botulinum Toxin). Clinically, modulating this target is vital for treating neuromuscular disorders such as dystonia, spasticity, and chronic migraine, as well as for cosmetic applications to reduce dynamic wrinkles.

Other names

SNAP-25Synaptosomal-associated protein 25kDaPresynaptic muscarinic receptorsPresynaptic nicotinic receptorsSNARE complex proteinsNeuromuscular junction presynaptic apparatus

Botulinum neurotoxins (Type A, C, E) proteolytically cleave SNAP-25, preventing the formation of the SNARE complex and subsequent exocytosis of acetylcholine. Presynaptic cholinergic receptors (M1, M2, alpha-3-beta-2) modulate the probability of acetylcholine release through feedback loops.